IMARC Group’s report titled “Orthobiologics Market Report by Product (Demineralized Bone Matrix, Allograft, Bone Morphogenetic Protein, Viscosupplementation Products, Synthetic Bone Substitutes, and Others), Type (Knee, Ankle, Hip, Wrist and Shoulder, Spine, and Others), Application (Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Fracture Recovery, Soft Tissue Injuries, Maxillofacial and Dental Applications), End User (Hospitals and Ambulatory Centers, Research and Academic Institutes, Dental Clinics and Facilities, Orthopedic Clinics), and Region 2025-2033”, The global orthobiologics market size reached USD 6.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 9.4 Billion by 2033, exhibiting a growth rate (CAGR) of 4.31% during 2025-2033.
Factors Affecting the Growth of the Orthobiologics Industry:
- Increasing Incidence of Musculoskeletal Disorders:
The orthobiologics market is growing because musculoskeletal disorders, like osteoarthritis, rheumatoid arthritis, and sports injuries, are becoming more common. This is happening due to an aging population, more sedentary lifestyles, and higher obesity rates. In 2024, more people are looking for treatment options that can help them recover faster without relying on surgery. Orthobiologics, which use biological materials to promote healing, are becoming popular for treating these conditions. These treatments, including stem cell therapy and platelet-rich plasma (PRP), help patients recover more quickly and effectively. As more people seek alternatives to surgery, the demand for orthobiologics is increasing, leading to more investment in new treatments.
- Technological Advancements in Regenerative Medicine:
Advances in regenerative medicine are helping the orthobiologics market grow. In 2024, new technologies like 3D bioprinting, gene therapy, and advanced materials are changing how orthobiologics are developed. 3D bioprinting, for example, allows for the creation of customized scaffolds that help tissue grow and heal. Nanotechnology is also being used to make treatments more effective. These technological breakthroughs are making orthobiologics better and more personalized for patients, improving treatment outcomes. As these innovations continue to develop, they will keep driving growth in the orthobiologics market and attract more investment.
- Growing Awareness and Acceptance of Minimally Invasive Procedures:
More people are becoming aware of and choosing minimally invasive procedures, which are surgeries that cause less trauma and have quicker recovery times. This trend is influencing the orthobiologics market, as these products help people heal faster after minimally invasive surgeries. In 2024, more patients are opting for outpatient procedures that let them go home the same day, which boosts the demand for orthobiologics. Education and awareness about the benefits of these treatments are increasing, leading to more acceptance of orthobiologics as a treatment option. As patients and healthcare providers embrace minimally invasive techniques, the demand for orthobiologics will continue to grow.
Grab a sample PDF of this report: https://www.imarcgroup.com/orthobiologics-market/requestsample
Leading Companies Operating in the Global Orthobiologics Industry:
- Arthrex Inc
- Globus Medical Inc.
- Integra LifeSciences
- Johnson & Johnson
- Medline Industries Inc.
- Medtronic plc
- NuVasive Inc
- Orthofix Medical Inc.
- Smith & Nephew plc
- Stryker Corporation
- Terumo Corporation
- Wright Medical Group N.V.
- Zimmer Biomet
Orthobiologics Market Report Segmentation:
By Product:
- Demineralized Bone Matrix
- Allograft
- Bone Morphogenetic Protein
- Viscosupplementation Products
- Synthetic Bone Substitutes
- Others
By Type:
- Knee
- Ankle
- Hip
- Wrist and Shoulder
- Spine
- Others
By Application:
- Osteoarthritis and Degenerative Arthritis
- Spinal Fusion
- Fracture Recovery
- Soft Tissue Injuries
- Maxillofacial and Dental Applications
By End User:
- Hospitals and Ambulatory Centers
- Research and Academic Institutes
- Dental Clinics and Facilities
- Orthopedic Clinics
Regional Insights:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Orthobiologics Market Trends:
The orthobiologics market is expected to grow significantly, driven by several important trends. In 2024, as healthcare providers focus more on personalized care, the demand for orthobiologics will rise. New developments in biomaterials and tissue engineering will allow treatments to be customized for individual patients, improving their effectiveness. Additionally, digital health technologies, like telemedicine, will help doctors better engage with patients and monitor their recovery, supporting the use of orthobiologics. As healthcare becomes more focused on cost-effective solutions, orthobiologics will be in high demand because they help reduce hospital stays and treatment costs. Collaboration between manufacturers, healthcare providers, and researchers will also lead to new innovations, ensuring orthobiologics meet the needs of patients. These trends will continue to shape the market, making orthobiologics an essential part of musculoskeletal treatment.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Tel No:(D) +91 120 433 0800
United States: +1–631–791–1145